These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 28723537

  • 1. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
    Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM.
    Eur Urol Focus; 2016 Jun; 2(2):210-218. PubMed ID: 28723537
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [Abstract] [Full Text] [Related]

  • 3. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T, Lu C, Gong W, Ge Z, Li R, Li X, Sun C, Li W, Long Q, Liu Q, Lai Y.
    Front Biosci (Landmark Ed); 2024 May 13; 29(5):186. PubMed ID: 38812297
    [Abstract] [Full Text] [Related]

  • 4. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
    Han LL, Wang SH, Yao MY, Zhou H.
    World J Diabetes; 2024 Jan 15; 15(1):92-104. PubMed ID: 38313849
    [Abstract] [Full Text] [Related]

  • 5. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB.
    BMC Cancer; 2019 Feb 08; 19(1):129. PubMed ID: 30736753
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
    Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang Y, Chen X, Chen X, Wang Z.
    Onco Targets Ther; 2021 Feb 08; 14():1441-1451. PubMed ID: 33664577
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C.
    Clin Cancer Res; 2017 Sep 01; 23(17):5311-5319. PubMed ID: 28606918
    [Abstract] [Full Text] [Related]

  • 13. Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma.
    Wang X, Wang T, Chen C, Wu Z, Bai P, Li S, Chen B, Liu R, Zhang K, Li W, Chen Y, Xing J.
    J Cell Biochem; 2019 Feb 01; 120(2):1492-1502. PubMed ID: 30304555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 16. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H, Shi X, Li H, Hui J, Liu R, Chen Z, Lu Y, Tan W.
    BMC Cancer; 2021 Dec 03; 21(1):1293. PubMed ID: 34861847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.